30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Bio Rad Laboratories Inc (BIO)

Track

Over the last 90 days, Bio Rad Laboratories Inc. has seen net insider selling totaling $135,597.00, with three transactions recorded. All recorded transactions were sales, with no purchases by insiders during this period. The company's stock has seen a 9.5% increase over the past 90 days.
Stock chart
Ticker: BIO Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Alles Institute for Medical Research Corp
Director; 10% Stockholder
1 sale — total 219,296 USD
Proposed sale 28 May 2026
Value US$884,284.09 | Price 50.20 | Shares 16,024
Sale 11 May 2026
Value US$4,430,840.44 | Price 49.78 | Shares 74,213
Proposed sale 11 May 2026
Value US$135,597.00 | Price 246.54 | Shares 550
Proposed sale 2 Dec 2025
Value US$247,978.56 | Price 319.56 | Shares 776
Proposed sale 18 Nov 2025
Value US$228,793.04 | Price 301.04 | Shares 760
Sale 6 Nov 2025
Value US$214,288.51 | Price 306.18 | Shares 700
Proposed sale 6 Nov 2025
Value US$214,633.08 | Price 306.18 | Shares 701
Proposed sale 5 Aug 2025
Value US$410,571.64 | Price 275.92 | Shares 1,488
Sale 14 Mar 2025
Value US$741,184.20 | Price 247.06 | Shares 3,000
Proposed sale 13 Mar 2025
Value US$780,000.00 | Price 260.00 | Shares 3,000
Proposed sale 11 Mar 2025
Value US$101,539.65 | Price 247.66 | Shares 410
Proposed sale 6 Nov 2024
Value US$1,120,934.04 | Price 373.64 | Shares 3,000
Proposed sale 12 Sep 2024
Value US$514,504.96 | Price 321.57 | Shares 1,600
Sale 6 Sep 2024
Value US$989,815.20 | Price 329.94 | Shares 3,000
Proposed sale 6 Sep 2024
Value US$989,815.20 | Price 329.94 | Shares 3,000
Proposed sale 4 Sep 2024
Value US$205,898.15 | Price 330.49 | Shares 623
Sale 4 Sep 2024
Value US$205,898.14 | Price 330.49 | Shares 623
Proposed sale 27 Aug 2024
Value US$308,224.62 | Price 311.34 | Shares 990
Sale 13 Jun 2024
Value US$104,023.46 | Price 281.91 | Shares 369
Proposed sale 13 Jun 2024
Value US$104,023.46 | Price 281.91 | Shares 369
Sale 28 Feb 2024
Value US$826,375.00 | Price 330.55 | Shares 2,500
Proposed sale 28 Feb 2024
Value US$826,362.50 | Price 330.55 | Shares 2,500
Sale 27 Feb 2024
Value US$1,008,000.00 | Price 336.00 | Shares 3,000
Proposed sale 27 Feb 2024
Value US$1,008,008.59 | Price 336.00 | Shares 3,000
Proposed sale 27 Feb 2024
Value US$616,181.00 | Price 335.25 | Shares 1,838
Proposed sale 12 Dec 2023
Value US$358,989.24 | Price 299.16 | Shares 1,200
Planned sale 12 Dec 2023
Value US$358,992.00 | Price 299.16 | Shares 1,200
Proposed sale 28 Nov 2023
Value US$195,873.04 | Price 305.10 | Shares 642
Sale 28 Nov 2023
Value US$195,874.20 | Price 305.10 | Shares 642
Proposed sale 28 Nov 2023
Value US$241,873.59 | Price 302.34 | Shares 800
Sale 30 Aug 2023
Value US$149,457.88 | Price 396.44 | Shares 377
Sale 30 Aug 2023
Value US$626,092.32 | Price 395.76 | Shares 1,582
Sale 30 Aug 2023
Value US$154,116.56 | Price 394.16 | Shares 391
Proposed sale 30 Aug 2023
Value US$923,550.00 | Price 393.00 | Shares 2,350
Proposed sale 23 Aug 2023
Value US$115,407.36 | Price 384.69 | Shares 300
Planned sale 23 Aug 2023
Value US$115,407.00 | Price 384.69 | Shares 300
Sale 15 Jun 2023
Value US$189,695.00 | Price 379.39 | Shares 500
Proposed sale 15 Jun 2023
Value US$189,692.50 | Price 379.39 | Shares 500
Sale 6 Jun 2023
Value US$66,658.68 | Price 368.28 | Shares 181
Sale 6 Jun 2023
Value US$6,394.04 | Price 368.49 | Shares 17
Proposed sale 6 Jun 2023
Value US$73,053.55 | Price 368.96 | Shares 198
Sale 3 May 2023
Value US$148,435.20 | Price 463.86 | Shares 320
Sale 3 May 2023
Value US$148,435.20 | Price 463.86 | Shares 320
Sale 8 Mar 2023
Value US$363,219.94 | Price 486.89 | Shares 746
Sale 8 Mar 2023
Value US$486,080.00 | Price 486.08 | Shares 1,000
Sale 10 Nov 2022
Value US$161.35 | Price 423.61 | Shares 0
Sale 10 Nov 2022
Value US$47,295.36 | Price 422.28 | Shares 112
Planned sale 10 Nov 2022
Value US$112,593.90 | Price 421.70 | Shares 267
Planned sale 5 Aug 2022
Value US$278,166.00 | Price 537.00 | Shares 518
Sale 12 Nov 2021
Value US$3,600,240.00 | Price 750.05 | Shares 4,800
Sale 11 Nov 2021
Value US$375,000.00 | Price 750.00 | Shares 500
Sale 11 Nov 2021
Value US$459,038.92 | Price 748.84 | Shares 613
Sale 11 Nov 2021
Value US$323,918.64 | Price 748.08 | Shares 433
Planned sale 4 Aug 2021
Value US$248,605.02 | Price 760.26 | Shares 327
Sale 19 Feb 2021
Value US$125,541.82 | Price 640.17 | Shares 196
Sale 19 Feb 2021
Value US$209,580.84 | Price 640.92 | Shares 327
Sale 19 Feb 2021
Value US$256,376.00 | Price 640.94 | Shares 400
Sale 15 Dec 2020
Value US$217,170.58 | Price 580.67 | Shares 374
Sale 6 Nov 2020
Value US$157,816.38 | Price 641.53 | Shares 246
Sale 6 Nov 2020
Value US$470,332.52 | Price 640.78 | Shares 734
Sale 6 Nov 2020
Value US$140,716.40 | Price 639.62 | Shares 220
Sale 19 Aug 2020
Value US$176,910.54 | Price 521.86 | Shares 339
Sale 19 Aug 2020
Value US$2,952,687.92 | Price 520.94 | Shares 5,668
Sale 19 Aug 2020
Value US$589,035.37 | Price 519.89 | Shares 1,133
Sale 19 Aug 2020
Value US$2,797,153.92 | Price 518.76 | Shares 5,392
Sale 19 Aug 2020
Value US$163,056.60 | Price 517.64 | Shares 315
Sale 18 Aug 2020
Value US$1,235,805.42 | Price 518.81 | Shares 2,382
Sale 1 Jun 2020
Value US$728,100.00 | Price 485.40 | Shares 1,500
Planned sale 13 May 2020
Value US$202,606.05 | Price 457.35 | Shares 443
Sale 4 Dec 2019
Value US$242,798.72 | Price 370.12 | Shares 656
Sale 4 Dec 2019
Value US$462,637.50 | Price 370.11 | Shares 1,250
Sale 11 Nov 2019
Value US$298,029.60 | Price 351.45 | Shares 848
Sale 12 Sep 2019
Value US$172,260.00 | Price 330.00 | Shares 522
Sale 12 Sep 2019
Value US$13,489.00 | Price 329.00 | Shares 41
Sale 12 Sep 2019
Value US$261,615.25 | Price 328.25 | Shares 797
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-28 2026-05-28 PrS Proposed sale
Alles Institute for Medical Research Corp

Director; 10% Stockholder

Non-Executive Director Large shareholder
16,024
50.20
US$884,284 		16,024 50.20 US$884,284
2026-05-13 2026-05-11 S Sale
ENGELHARDT EVA ANETTE

EVP, President, CDG

Officer
74,213 +19.2%
49.78
US$4,430,840 		74,213 +19.2% 49.78 US$4,430,840
2026-05-11 2026-05-11 PrS Proposed sale
EVA ENGELHARDT

Officer

Officer
34,306
313.70
US$3,993,048 		34,306 313.70 US$3,993,048
2025-12-02 2025-12-02 PrS Proposed sale
3.0
MICHAEL W CROWLEY

Officer

Officer
776
319.56
US$247,979 		776 319.56 US$247,979
2025-11-18 2025-11-18 PrS Proposed sale
Alles Institute for Medical Research Corp

Director; 10% Stockholder

Non-Executive Director Large shareholder
760
301.04
US$228,793 		760 301.04 US$228,793
2025-11-10 2025-11-06 S Sale
2.4
BARRY JAMES

EVP, President, LSG

Officer
700 -57.9%
306.18
US$214,289 		700 -57.9% 306.18 US$214,289
2025-11-06 2025-11-06 PrS Proposed sale
2.4
JAMES BARRY

Officer

Officer
701
306.18
US$214,633 		701 306.18 US$214,633
2025-08-05 2025-08-05 PrS Proposed sale
3.0
MICHAEL W CROWLEY

Officer

Officer
1,488
275.92
US$410,572 		1,488 275.92 US$410,572
2025-03-18 2025-03-14 S Sale
3.0
Crowley Michael

EVP, GBL Commercial Operations

Officer
3,000 -26.9%
247.06
US$741,184 		3,000 -26.9% 247.06 US$741,184
2025-03-13 2025-03-13 PrS Proposed sale
3.0
Crowley Michael

Officer

Officer
3,000
260.00
US$780,000 		3,000 260.00 US$780,000
2025-03-11 2025-03-11 PrS Proposed sale
Alles Institute for Medical Research Corp

Director; 10% Stockholder

Non-Executive Director Large shareholder
410
247.66
US$101,540 		410 247.66 US$101,540
2024-11-06 2024-11-06 PrS Proposed sale
2.1
Last Andrew J.

Officer

Officer
3,000
373.64
US$1,120,934 		3,000 373.64 US$1,120,934
2024-09-12 2024-09-12 PrS Proposed sale
2.1
Last Andrew J.

Officer

Officer
1,600
321.57
US$514,505 		1,600 321.57 US$514,505
2024-09-10 2024-09-06 S Sale
2.1
Last Andrew J.

EVP, Chief Operating Officer

Officer
3,000 -28.4%
329.94
US$989,815 		3,000 -28.4% 329.94 US$989,815
2024-09-06 2024-09-06 PrS Proposed sale
2.1
Last Andrew J.

Officer

Officer
3,000
329.94
US$989,815 		3,000 329.94 US$989,815
2024-09-04 2024-09-04 PrS Proposed sale
2.4
BARRY JAMES

Officer

Officer
623
330.49
US$205,898 		623 330.49 US$205,898
2024-09-04 2024-09-04 S Sale
2.4
BARRY JAMES

EVP, President, LSG

Officer
623 -81.0%
330.49
US$205,898 		623 -81.0% 330.49 US$205,898
2024-08-27 2024-08-27 PrS Proposed sale
Alles Institute for Medical Research Corp

Director; 10% Stockholder

Non-Executive Director Large shareholder
990
311.34
US$308,225 		990 311.34 US$308,225
2024-06-14 2024-06-13 S Sale
3.0
Crowley Michael

EVP, GBL Commercial Operations

Officer
369 -5.3%
281.91
US$104,023 		369 -5.3% 281.91 US$104,023
2024-06-13 2024-06-13 PrS Proposed sale
3.0
Crowley Michael

Officer

Officer
369
281.91
US$104,023 		369 281.91 US$104,023
2024-02-29 2024-02-28 S Sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
2,500 -42.4%
330.55
US$826,375 		2,500 -42.4% 330.55 US$826,375
2024-02-28 2024-02-28 PrS Proposed sale
3.7
ERNST TIMOTHY S

Officer

Officer
2,500
330.55
US$826,362 		2,500 330.55 US$826,362
2024-02-28 2024-02-27 S Sale
3.0
Crowley Michael

EVP, GBL Commercial Operations

Officer
3,000 -30.2%
336.00
US$1,008,000 		3,000 -30.2% 336.00 US$1,008,000
2024-02-27 2024-02-27 PrS Proposed sale
3.0
Crowley Michael

Officer

Officer
3,000
336.00
US$1,008,009 		3,000 336.00 US$1,008,009
2024-02-27 2024-02-27 PrS Proposed sale
WRIGHT DARA

Officer

Officer
1,838
335.25
US$616,181 		1,838 335.25 US$616,181
2023-12-12 2023-12-12 PrS Proposed sale
WRIGHT DARA

Officer

Officer
1,200
299.16
US$358,989 		1,200 299.16 US$358,989
2023-12-12 2023-12-12 PlS Planned sale
WRIGHT DARA

EVP, President, CDG

Officer
1,200 -44.5%
299.16
US$358,992 		1,200 -44.5% 299.16 US$358,992
2023-11-28 2023-11-28 PrS Proposed sale
3.0
Crowley Michael

Officer

Officer
642
305.10
US$195,873 		642 305.10 US$195,873
2023-11-28 2023-11-28 PrS Proposed sale
Alles Institute for Medical Research Corp

Director; 10% Stockholder

Non-Executive Director Large shareholder
800
302.34
US$241,874 		800 302.34 US$241,874
2023-11-28 2023-11-28 S Sale
3.0
Crowley Michael

EVP, GBL Commercial Operations

Officer
642 -8.5%
305.10
US$195,874 		642 -8.5% 305.10 US$195,874
2023-08-31 2023-08-30 S Sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
377 -13.5%
396.44
US$149,458 		377 -13.5% 396.44 US$149,458
2023-08-31 2023-08-30 S Sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
1,582 -36.2%
395.76
US$626,092 		1,582 -36.2% 395.76 US$626,092
2023-08-31 2023-08-30 S Sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
391 -8.2%
394.16
US$154,117 		391 -8.2% 394.16 US$154,117
2023-08-30 2023-08-30 PrS Proposed sale
3.7
ERNST TIMOTHY S

Officer

Officer
2,350
393.00
US$923,550 		2,350 393.00 US$923,550
2023-08-23 2023-08-23 PrS Proposed sale
3.7
ERNST TIMOTHY S

Officer

Officer
300
384.69
US$115,407 		300 384.69 US$115,407
2023-08-23 2023-08-23 PlS Planned sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
300 -11.0%
384.69
US$115,407 		300 -11.0% 384.69 US$115,407
2023-06-16 2023-06-15 S Sale
3.0
Crowley Michael

EVP, GBL Commercial Operations

Officer
500 -7.6%
379.39
US$189,695 		500 -7.6% 379.39 US$189,695
2023-06-15 2023-06-15 PrS Proposed sale
3.0
Crowley Michael

Officer

Officer
500
379.39
US$189,692 		500 379.39 US$189,692
2023-06-07 2023-06-06 S Sale
1.9
RAMALINGAM AJIT

SVP, Chief Accounting Officer

Officer
181 -100.0%
368.28
US$66,659 		181 -100.0% 368.28 US$66,659
2023-06-07 2023-06-06 S Sale
1.9
RAMALINGAM AJIT

SVP, Chief Accounting Officer

Officer
17 -8.7%
368.49
US$6,394 		17 -8.7% 368.49 US$6,394
2023-06-06 2023-06-06 PrS Proposed sale
1.9
RAMALINGAM AJIT

Officer

Officer
198
368.96
US$73,054 		198 368.96 US$73,054
2024-05-01 2023-05-03 S Sale
3.1
SCHWARTZ STEVEN D
Large shareholder
320 -17.6%
463.86
US$148,435 		320 -17.6% 463.86 US$148,435
2024-05-01 2023-05-03 S Sale
3.1
SCHWARTZ STEVEN D
Large shareholder
320 -17.6%
463.86
US$148,435 		320 -17.6% 463.86 US$148,435
2023-03-08 2023-03-08 S Sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
746 -21.8%
486.89
US$363,220 		746 -21.8% 486.89 US$363,220
2023-03-08 2023-03-08 S Sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
1,000 -22.6%
486.08
US$486,080 		1,000 -22.6% 486.08 US$486,080
2022-11-14 2022-11-10 S Sale
1.9
RAMALINGAM AJIT

SVP, Chief Accounting Officer

Officer
0 -100.0%
423.61
US$161 		0 -100.0% 423.61 US$161
2022-11-14 2022-11-10 S Sale
1.9
RAMALINGAM AJIT

SVP, Chief Accounting Officer

Officer
112 -99.7%
422.28
US$47,295 		112 -99.7% 422.28 US$47,295
2022-11-14 2022-11-10 PlS Planned sale
1.9
RAMALINGAM AJIT

SVP, Chief Accounting Officer

Officer
267 -70.4%
421.70
US$112,594 		267 -70.4% 421.70 US$112,594
2022-08-08 2022-08-05 PlS Planned sale
1.9
RAMALINGAM AJIT

SVP, Chief Accounting Officer

Officer
518 -84.0%
537.00
US$278,166 		518 -84.0% 537.00 US$278,166
2021-11-15 2021-11-12 S Sale
3.3
TUMOLO ANNETTE

Executive Vice President

Officer
4,800 -51.1%
750.05
US$3,600,240 		4,800 -51.1% 750.05 US$3,600,240
2021-11-15 2021-11-11 S Sale
3.3
TUMOLO ANNETTE

Executive Vice President

Officer
500 -9.8%
750.00
US$375,000 		500 -9.8% 750.00 US$375,000
2021-11-15 2021-11-11 S Sale
3.3
TUMOLO ANNETTE

Executive Vice President

Officer
613 -10.7%
748.84
US$459,039 		613 -10.7% 748.84 US$459,039
2021-11-15 2021-11-11 S Sale
3.3
TUMOLO ANNETTE

Executive Vice President

Officer
433 -7.1%
748.08
US$323,919 		433 -7.1% 748.08 US$323,919
2021-08-05 2021-08-04 PlS Planned sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
327 -26.2%
760.26
US$248,605 		327 -26.2% 760.26 US$248,605
2021-02-22 2021-02-19 S Sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
196 -13.8%
640.17
US$125,542 		196 -13.8% 640.17 US$125,542
2021-02-22 2021-02-19 S Sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
327 -18.8%
640.92
US$209,581 		327 -18.8% 640.92 US$209,581
2021-02-22 2021-02-19 S Sale
3.7
ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
400 -18.7%
640.94
US$256,376 		400 -18.7% 640.94 US$256,376
2020-12-17 2020-12-15 S Sale
3.0
Crowley Michael

EVP, GBL Commercial Operations

Officer
374 -9.3%
580.67
US$217,171 		374 -9.3% 580.67 US$217,171
2020-11-10 2020-11-06 S Sale
3.3
TUMOLO ANNETTE

Executive Vice President

Officer
246 -5.6%
641.53
US$157,816 		246 -5.6% 641.53 US$157,816
2020-11-10 2020-11-06 S Sale
3.3
TUMOLO ANNETTE

Executive Vice President

Officer
734 -14.4%
640.78
US$470,333 		734 -14.4% 640.78 US$470,333
2020-11-10 2020-11-06 S Sale
3.3
TUMOLO ANNETTE

Executive Vice President

Officer
220 -4.1%
639.62
US$140,716 		220 -4.1% 639.62 US$140,716
2020-08-21 2020-08-19 S Sale
1.7
Magni Giovanni

EVP, Chief Strategy Officer

Officer
339 -1.6%
521.86
US$176,911 		339 -1.6% 521.86 US$176,911
2020-08-21 2020-08-19 S Sale
1.7
Magni Giovanni

EVP, Chief Strategy Officer

Officer
5,668 -21.2%
520.94
US$2,952,688 		5,668 -21.2% 520.94 US$2,952,688
2020-08-21 2020-08-19 S Sale
1.7
Magni Giovanni

EVP, Chief Strategy Officer

Officer
1,133 -4.1%
519.89
US$589,035 		1,133 -4.1% 519.89 US$589,035
2020-08-21 2020-08-19 S Sale
1.7
Magni Giovanni

EVP, Chief Strategy Officer

Officer
5,392 -16.2%
518.76
US$2,797,154 		5,392 -16.2% 518.76 US$2,797,154
2020-08-21 2020-08-19 S Sale
1.7
Magni Giovanni

EVP, Chief Strategy Officer

Officer
315 -0.9%
517.64
US$163,057 		315 -0.9% 517.64 US$163,057
2020-08-19 2020-08-18 S Sale
1.7
Magni Giovanni

EVP, Chief Strategy Officer

Officer
2,382 -16.1%
518.81
US$1,235,805 		2,382 -16.1% 518.81 US$1,235,805
2020-06-02 2020-06-01 S Sale
3.0
Crowley Michael

EVP, GBL Commercial Operations

Officer
1,500 -39.4%
485.40
US$728,100 		1,500 -39.4% 485.40 US$728,100
2020-05-14 2020-05-13 PlS Planned sale
HUTTON RONALD W

Vice President and Treasurer

Officer
443 -9.7%
457.35
US$202,606 		443 -9.7% 457.35 US$202,606
2019-12-05 2019-12-04 S Sale ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
656 -59.0%
370.12
US$242,799 		656 -59.0% 370.12 US$242,799
2019-12-05 2019-12-04 S Sale ERNST TIMOTHY S

EVP, General Counsel & Sec

Officer
1,250 -52.9%
370.11
US$462,638 		1,250 -52.9% 370.11 US$462,638
2019-11-12 2019-11-11 S Sale STARK JAMES R

VP, Corporate Controller

Officer
848 -100.0%
351.45
US$298,030 		848 -100.0% 351.45 US$298,030
2019-09-16 2019-09-12 S Sale
3.3
TUMOLO ANNETTE

Executive Vice President
522 -17.8%
330.00
US$172,260 		522 -17.8% 330.00 US$172,260
2019-09-13 2019-09-12 S Sale
1.4
HERTIA JOHN

Executive Vice President
41 -0.2%
329.00
US$13,489 		41 -0.2% 329.00 US$13,489
2019-09-13 2019-09-12 S Sale
1.4
HERTIA JOHN

Executive Vice President
797 -4.1%
328.25
US$261,615 		797 -4.1% 328.25 US$261,615
Explore more

More insider trading research around Bio Rad Laboratories Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America